Galveston firm gets $10 million to study radiation antidote
By MYER LEE The Daily News Dec 13, 2020 Darrell Carney’s company, Chrysalis BioTheraputics, received $10.4 million to continue developing TP508, a drug that remedies the effects of radiation exposure. JENNIFER REYNOLDS/The Daily News Chrysalis BioTherapeutics, a clinical stage biopharmaceutical company based in Galveston, is positioned to revolutionize lives worldwide. Chrysalis recently received $10.4 million